Other Events ·
iSpecimen Inc. entered into a Settlement Agreement with WestPark Capital to resolve an arbitration dispute regarding…
ISPCiSpecimen Inc.
iSpecimen Inc. entered into a Settlement Agreement with WestPark Capital to resolve an arbitration dispute regarding investment banking services for the company's July 2025 public offering, which raised approximately $4.0 million in gross proceeds. WestPark had sought damages of $269,999.91 plus interest and fees; the Company paid $97,500 to settle all claims without admitting liability. The Engagement Agreements were terminated entirely, including any tail fees or rights of first refusal, with each party bearing its own costs. The settlement payment is expected to be recorded as a charge in the quarter ending September 30, 2026. iSpecimen Inc. operates in the biotechnology industry, providing specimen collection and logistics services.